Literature DB >> 2065858

The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients.

R W James1, D Pometta.   

Abstract

The distribution and composition of lipoproteins spanning the very low density and low density lipoprotein spectra have been analysed in ten poorly-controlled, male, Type 2 (non-insulin-dependent), diabetic patients pre-disposed to mild, secondary hypertriglyceridaemia. As compared to age-matched control subjects, the diabetic patients displayed grossly modified, distinctly atherogenic lipoprotein profiles. Modifications were not limited to the very low density lipoprotein profile, as would be expected from the pre-treatment hypertriglyceridaemia. There was also an aberrant low density lipoprotein profile, which was not evident from plasma cholesterol measurements, especially as the diabetic patients at entry were well matched to control subjects with respect to plasma levels of this lipid. Compositional abnormalities were also observed in the poorly-controlled diabetic group, although these were less marked than the distributional changes. There were substantial improvements of the abnormalities detailed above, even over a short treatment period (two weeks), with therapy designed primarily to ameliorate metabolic control. The data suggest that, in the presence of poor metabolic control and hypertriglyceridaemia, occult, atherogenic modifications of low density lipoproteins can occur. The results argue in favour of strict control of triglyceride levels even in diabetic patients with apparently acceptable cholesterol levels.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2065858     DOI: 10.1007/BF00405083

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  44 in total

1.  Catabolism of very low density lipoprotein B apoprotein in man.

Authors:  M F Reardon; N H Fidge; P J Nestel
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

2.  Heterogeneity of plasma low density lipoproteins manifestations of the physiologic phenomenon in man.

Authors:  W R Fisher
Journal:  Metabolism       Date:  1983-03       Impact factor: 8.694

3.  Differences in lipoprotein subfraction composition and distribution between type I diabetic men and control subjects.

Authors:  R W James; D Pometta
Journal:  Diabetes       Date:  1990-10       Impact factor: 9.461

Review 4.  Lipoprotein subspecies and risk of coronary disease.

Authors:  T A Musliner; R M Krauss
Journal:  Clin Chem       Date:  1988       Impact factor: 8.327

Review 5.  Hyperlipidaemia of diabetes.

Authors:  G F Gibbons
Journal:  Clin Sci (Lond)       Date:  1986-11       Impact factor: 6.124

6.  Concentrations of lipids and apolipoproteins in patients with clinically well-controlled insulin-dependent and non-insulin-dependent diabetes.

Authors:  J Joven; E Vilella; B Costa; P R Turner; C Richart; L Masana
Journal:  Clin Chem       Date:  1989-05       Impact factor: 8.327

7.  Low-density lipoprotein subclass patterns and risk of myocardial infarction.

Authors:  M A Austin; J L Breslow; C H Hennekens; J E Buring; W C Willett; R M Krauss
Journal:  JAMA       Date:  1988-10-07       Impact factor: 56.272

8.  Quantitative studies of very low density lipoprotein: conversion to low density lipoprotein in normal controls and primary hyperlipidaemic states and the role of direct secretion of low density lipoprotein in heterozygous familial hypercholesterolaemia.

Authors:  E D Janus; A Nicoll; R Wootton; P R Turner; P J Magill; B Lewis
Journal:  Eur J Clin Invest       Date:  1980-04       Impact factor: 4.686

9.  Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.

Authors:  C J Packard; A Munro; A R Lorimer; A M Gotto; J Shepherd
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  The metabolism of apolipoprotein B in subjects with hypertriglyceridemia and polydisperse LDL.

Authors:  W R Fisher; L A Zech; P Bardalaye; G Warmke; M Berman
Journal:  J Lipid Res       Date:  1980-08       Impact factor: 5.922

View more
  5 in total

Review 1.  Strategies for the management of diabetic dyslipidaemia.

Authors:  M R Taskinen
Journal:  Drugs       Date:  1999       Impact factor: 9.546

2.  Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes.

Authors:  Anne Hiukka; Jamila Fruchart-Najib; Eeva Leinonen; Hannele Hilden; Jean-Charles Fruchart; Marja-Riitta Taskinen
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

3.  The effect of low density lipoprotein composition on the regulation of cellular cholesterol synthesis: a comparison in diabetic and non-diabetic subjects.

Authors:  D Owens; S McBrinn; P Collins; A Johnson; G H Tomkin
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

4.  Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations.

Authors:  M C Blatter Garin; C Abbott; S Messmer; M Mackness; P Durrington; D Pometta; R W James
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

Review 5.  Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).

Authors:  B H Wolffenbuttel; T W van Haeften
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.